Aurora Cannabis reiterates call for shareholders to reject revised Curaleaf bid
Aurora Cannabis' board reaffirmed its opposition to Curaleaf's revised offer for all outstanding common shares, citing significant undervaluation. The offer, revised October 6, 2026, remains open until December 4, 2026. Higher consideration consists principally of Curaleaf shares; the board warned that a significant po